ATE433452T1 - Imidazoä1,2-cüpyrimidinylessigsäurederivate - Google Patents

Imidazoä1,2-cüpyrimidinylessigsäurederivate

Info

Publication number: ATE433452T1
Authority: AT; Austria
Prior art keywords: diseases; allergic; imidazo; acid derivative; treatment
Prior art date: 2004-01-31

Application number

AT05706922T

Other languages

English (en)

Inventor

Tai-Wei Ly

Takashi Yoshino

Yuki Takekawa

Takuya Shintani

Hiromi Sugimoto

Kevin B Bacon

Klaus Urbahns

Original Assignee

Actimis Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-01-31

Filing date

2005-01-19

Publication date

2009-06-15

2005-01-19 Application filed by Actimis Pharmaceuticals Inc filed Critical Actimis Pharmaceuticals Inc

2009-06-15 Application granted granted Critical

2009-06-15 Publication of ATE433452T1 publication Critical patent/ATE433452T1/de

Links

239000002253 acid Substances 0.000 title 1
201000010099 disease Diseases 0.000 abstract 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
JELCUCXNEYEZOO-UHFFFAOYSA-N 2-imidazo[1,2-c]pyrimidin-2-ylacetic acid Chemical class C1=NC=CC2=NC(CC(=O)O)=CN21 JELCUCXNEYEZOO-UHFFFAOYSA-N 0.000 abstract 2
102000009389 Prostaglandin D receptors Human genes 0.000 abstract 2
108050000258 Prostaglandin D receptors Proteins 0.000 abstract 2
238000011282 treatment Methods 0.000 abstract 2
208000016557 Acute basophilic leukemia Diseases 0.000 abstract 1
208000032671 Allergic granulomatous angiitis Diseases 0.000 abstract 1
208000006344 Churg-Strauss Syndrome Diseases 0.000 abstract 1
206010009900 Colitis ulcerative Diseases 0.000 abstract 1
206010010744 Conjunctivitis allergic Diseases 0.000 abstract 1
208000011231 Crohn disease Diseases 0.000 abstract 1
201000004624 Dermatitis Diseases 0.000 abstract 1
206010012438 Dermatitis atopic Diseases 0.000 abstract 1
208000018428 Eosinophilic granulomatosis with polyangiitis Diseases 0.000 abstract 1
102000011652 Formyl peptide receptors Human genes 0.000 abstract 1
108010076288 Formyl peptide receptors Proteins 0.000 abstract 1
108091006027 G proteins Proteins 0.000 abstract 1
102000030782 GTP binding Human genes 0.000 abstract 1
108091000058 GTP-Binding Proteins 0.000 abstract 1
208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
208000019693 Lung disease Diseases 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
201000004681 Psoriasis Diseases 0.000 abstract 1
206010039085 Rhinitis allergic Diseases 0.000 abstract 1
210000001744 T-lymphocyte Anatomy 0.000 abstract 1
210000004241 Th2 cell Anatomy 0.000 abstract 1
201000006704 Ulcerative Colitis Diseases 0.000 abstract 1
206010052568 Urticaria chronic Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
208000002205 allergic conjunctivitis Diseases 0.000 abstract 1
208000026935 allergic disease Diseases 0.000 abstract 1
201000010105 allergic rhinitis Diseases 0.000 abstract 1
230000003042 antagnostic effect Effects 0.000 abstract 1
206010003246 arthritis Diseases 0.000 abstract 1
208000006673 asthma Diseases 0.000 abstract 1
208000024998 atopic conjunctivitis Diseases 0.000 abstract 1
201000008937 atopic dermatitis Diseases 0.000 abstract 1
208000010668 atopic eczema Diseases 0.000 abstract 1
210000003651 basophil Anatomy 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
208000024376 chronic urticaria Diseases 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
210000003979 eosinophil Anatomy 0.000 abstract 1
208000027866 inflammatory disease Diseases 0.000 abstract 1
210000000265 leukocyte Anatomy 0.000 abstract 1
206010024378 leukocytosis Diseases 0.000 abstract 1
230000000414 obstructive effect Effects 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
201000009890 sinusitis Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Otolaryngology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AT05706922T 2004-01-31 2005-01-19 Imidazoä1,2-cüpyrimidinylessigsäurederivate ATE433452T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP04002144		2004-01-31
PCT/EP2005/000475 WO2005073234A2 (en)	2004-01-31	2005-01-19	Imidazo[1,2-c]pyrimidinylacetic acid derivatives

Publications (1)

Publication Number	Publication Date
ATE433452T1 true ATE433452T1 (de)	2009-06-15

Family

ID=34814234

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05706922T ATE433452T1 (de)	2004-01-31	2005-01-19	Imidazoä1,2-cüpyrimidinylessigsäurederivate

Country Status (23)

Country	Link
US (1)	US7750014B2 (de)
EP (1)	EP1718649B1 (de)
JP (1)	JP4996257B2 (de)
KR (1)	KR101207428B1 (de)
CN (1)	CN100584844C (de)
AT (1)	ATE433452T1 (de)
AU (1)	AU2005209381B2 (de)
BR (1)	BRPI0507123A (de)
CA (1)	CA2551778C (de)
CY (1)	CY1109274T1 (de)
DE (1)	DE602005014849D1 (de)
DK (1)	DK1718649T3 (de)
ES (1)	ES2326896T3 (de)
IL (1)	IL177083A (de)
MX (1)	MXPA06007674A (de)
NO (1)	NO20063878L (de)
NZ (1)	NZ548396A (de)
PL (1)	PL1718649T3 (de)
PT (1)	PT1718649E (de)
RU (1)	RU2373208C2 (de)
SI (1)	SI1718649T1 (de)
WO (1)	WO2005073234A2 (de)
ZA (1)	ZA200605387B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL1833791T3 (pl)	2004-12-27	2011-12-30	Actelion Pharmaceuticals Ltd	Pochodne 2,3,4,9-tetrahydro-1H-karbazolu jako antagonisty receptora CRTH2
KR101411820B1 (ko)	2006-08-07	2014-06-24	액테리온 파마슈티칼 리미티드	(3-아미노-1,2,3,4-테트라하이드로-9ｈ-카르바졸-9-일)-아세트산 유도체
US20100048579A1 (en) *	2007-04-13	2010-02-25	Luca Arista	Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonists
UA99138C2 (ru) *	2007-06-21	2012-07-25	Актимис Фармасьютикалз, Инк.	Частичка антагониста crth2 (варианты)
KR20100061746A (ko) *	2007-09-25	2010-06-08	액티미스 파마수티컬스 인코포레이티드	Ｃｒｔｈ２ 길항제로서의 ２－ｓ－벤질 치환된 피리미딘
PT2205569E (pt) *	2007-09-25	2012-05-25	Actimis Pharmaceuticals Inc	Alquiltiopirimidinas como antagonistas de crth2
WO2009102893A2 (en)	2008-02-14	2009-08-20	Amira Pharmaceuticals, Inc.	CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors
WO2009145989A2 (en)	2008-04-02	2009-12-03	Amira Pharmaceuticals, Inc.	Aminoalkylphenyl antagonists of prostaglandin d2 receptors
WO2010027448A1 (en) *	2008-09-02	2010-03-11	Actimis Pharmaceuticals Inc.	Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists
WO2010057118A2 (en)	2008-11-17	2010-05-20	Amira Pharmaceuticals, Inc.	Heterocyclic antagonists of prostaglandin d2 receptors
WO2011117798A1 (en)	2010-03-22	2011-09-29	Actelion Pharmaceuticals Ltd	3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
JP5800898B2 (ja)	2010-07-05	2015-10-28	アクテリオンファーマシューティカルズリミテッドＡｃｔｅｌｉｏｎＰｈａｒｍａｃｅｕｔｉｃａｌｓＬｔｄ	１−フェニル−置換ヘテロシクリル誘導体及びプロスタグランジンｄ２受容体調節剤としてのそれらの使用
DE102011003315A1 (de)	2011-01-28	2012-08-02	Bayer Schering Pharma Aktiengesellschaft	Annellierte Pyrimindine und Triazine und ihre Verwendung
DE102010031149A1 (de)	2010-07-09	2012-01-12	Bayer Schering Pharma Aktiengesellschaft	Annellierte Pyrimidine und Triazine und ihre Verwendung
PH12013500055A1 (en)	2010-07-09	2017-08-23	Bayer Ip Gmbh	Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases
US8927559B2 (en)	2010-10-11	2015-01-06	Merck Sharp & Dohme Corp.	Quinazolinone-type compounds as CRTH2 antagonists
EP2457900A1 (de)	2010-11-25	2012-05-30	Almirall, S.A.	Neue Pyrazolderivate mit CRTH2-antagonistischem Verhalten
MY165623A (en)	2011-04-14	2018-04-18	Idorsia Pharmaceuticals Ltd	7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators
SG11201402796SA (en)	2011-12-16	2014-06-27	Atopix Therapeutics Ltd	Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
RU2014129613A (ru)	2011-12-21	2016-02-10	Актелион Фармасьютиклз Лтд	Гетероциклильные производные и их применение в качестве модуляторов рецептора простагландина d2
DE102012200349A1 (de)	2012-01-11	2013-07-11	Bayer Intellectual Property Gmbh	Substituierte annellierte Pyrimidine und Triazine und ihre Verwendung
DE102012200360A1 (de)	2012-01-11	2013-07-11	Bayer Intellectual Property Gmbh	Substituierte Triazine und ihre Verwendung
JP6140738B2 (ja)	2012-03-06	2017-05-31	バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＧｍｂＨ	置換アザ二環およびその使用
US9169270B2 (en)	2012-07-05	2015-10-27	Actelion Pharmaceuticals Ltd.	1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators
HRP20181555T1 (hr)	2014-03-17	2018-11-30	Idorsia Pharmaceuticals Ltd	Derivati azaindol-octene kiseline i njihova uporaba kao modulatora receptora prostaglandina d2
RU2016140708A (ru)	2014-03-18	2018-04-18	Идорсиа Фармасьютиклз Лтд	Производные азаиндол уксусной кислоты и их применение в качестве модуляторов рецептора простагландина d2
PL3350179T3 (pl)	2015-09-15	2021-08-02	Idorsia Pharmaceuticals Ltd	Krystaliczne postacie
KR20190103507A (ko)	2018-02-12	2019-09-05	김강민	지하철 혼잡도 알림 시스템
WO2019139462A2 (ko) *	2019-02-21	2019-07-18	엘지전자 주식회사	하차 시점 알림 방법 및 사용자 단말
TW202100015A (zh)	2019-02-28	2021-01-01	瑞士商先正達農作物保護公司	具有含硫取代基之殺有害生物活性雜環衍生物
CN118141793A (zh) *	2022-05-17	2024-06-07	中国医学科学院基础医学研究所	二甲双胍及其它含胍化合物溶解夏科-莱登结晶并缓解急性肺损伤炎症中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE790679A (fr)	1971-11-03	1973-04-27	Ici Ltd	Derives de l'indole
GB9125842D0 (en)	1991-12-04	1992-02-05	Ici Plc	Heterocyclic derivatives
MXPA01007019A (es) *	1999-11-10	2002-09-18	Johnson & Johnson	2-aril-3-(heteroaril)-imidazo[1,2-a]pirimidinas, sustituidas y composiciones farmaceuticas relacionados y metodos.
JP2001302667A (ja) *	2000-04-28	2001-10-31	Bayer Ag	イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体
US6878522B2 (en)	2000-07-07	2005-04-12	Baiyong Li	Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
EP1413306A1 (de)	2002-10-21	2004-04-28	Warner-Lambert Company LLC	Tetrahydrochinolin-Derivate als CRTH2 Antagonisten
AU2003297398B2 (en) *	2002-12-20	2009-09-24	Amgen Inc.	Asthma and allergic inflammation modulators
ATE316077T1 (de) *	2003-04-25	2006-02-15	Actimis Pharmaceuticals Inc	Pyrimidin-essigsäure derivate geeignet zur behandlung von crth2-bedingten krankheiten

2005
- 2005-01-19 NZ NZ548396A patent/NZ548396A/en not_active IP Right Cessation
- 2005-01-19 WO PCT/EP2005/000475 patent/WO2005073234A2/en not_active Ceased
- 2005-01-19 ES ES05706922T patent/ES2326896T3/es not_active Expired - Lifetime
- 2005-01-19 SI SI200530724T patent/SI1718649T1/sl unknown
- 2005-01-19 PL PL05706922T patent/PL1718649T3/pl unknown
- 2005-01-19 JP JP2006550019A patent/JP4996257B2/ja not_active Expired - Fee Related
- 2005-01-19 DE DE602005014849T patent/DE602005014849D1/de not_active Expired - Lifetime
- 2005-01-19 AU AU2005209381A patent/AU2005209381B2/en not_active Ceased
- 2005-01-19 CA CA2551778A patent/CA2551778C/en not_active Expired - Fee Related
- 2005-01-19 DK DK05706922T patent/DK1718649T3/da active
- 2005-01-19 AT AT05706922T patent/ATE433452T1/de active
- 2005-01-19 PT PT05706922T patent/PT1718649E/pt unknown
- 2005-01-19 US US10/585,429 patent/US7750014B2/en not_active Expired - Fee Related
- 2005-01-19 MX MXPA06007674A patent/MXPA06007674A/es active IP Right Grant
- 2005-01-19 RU RU2006131304/04A patent/RU2373208C2/ru not_active IP Right Cessation
- 2005-01-19 CN CN200580010462A patent/CN100584844C/zh not_active Expired - Fee Related
- 2005-01-19 ZA ZA200605387A patent/ZA200605387B/en unknown
- 2005-01-19 BR BRPI0507123-2A patent/BRPI0507123A/pt not_active IP Right Cessation
- 2005-01-19 EP EP05706922A patent/EP1718649B1/de not_active Expired - Lifetime
2006
- 2006-07-25 IL IL177083A patent/IL177083A/en not_active IP Right Cessation
- 2006-08-29 KR KR1020067017478A patent/KR101207428B1/ko not_active Expired - Fee Related
- 2006-08-31 NO NO20063878A patent/NO20063878L/no not_active Application Discontinuation
2009
- 2009-08-06 CY CY20091100834T patent/CY1109274T1/el unknown

Also Published As

Publication number	Publication date
ZA200605387B (en)	2008-05-28
JP4996257B2 (ja)	2012-08-08
KR20060130187A (ko)	2006-12-18
DE602005014849D1 (de)	2009-07-23
CN100584844C (zh)	2010-01-27
KR101207428B1 (ko)	2012-12-04
NO20063878L (no)	2006-10-11
US20090012102A1 (en)	2009-01-08
SI1718649T1 (sl)	2009-10-31
CY1109274T1 (el)	2014-07-02
EP1718649B1 (de)	2009-06-10
BRPI0507123A (pt)	2007-06-19
DK1718649T3 (da)	2009-08-24
IL177083A (en)	2011-10-31
EP1718649A2 (de)	2006-11-08
HK1101969A1 (en)	2007-11-02
ES2326896T3 (es)	2009-10-21
WO2005073234A3 (en)	2005-10-06
RU2006131304A (ru)	2008-03-10
CA2551778A1 (en)	2005-08-11
MXPA06007674A (es)	2006-09-04
PT1718649E (pt)	2009-08-06
NZ548396A (en)	2010-06-25
WO2005073234A2 (en)	2005-08-11
PL1718649T3 (pl)	2009-11-30
AU2005209381B2 (en)	2011-06-30
US7750014B2 (en)	2010-07-06
IL177083A0 (en)	2006-12-10
AU2005209381A1 (en)	2005-08-11
CN1938310A (zh)	2007-03-28
JP2007519659A (ja)	2007-07-19
CA2551778C (en)	2013-10-22
RU2373208C2 (ru)	2009-11-20

Legal Events

Date

Code

Title

Description

2010-01-15

UEP

Publication of translation of european patent specification

Ref document number: 1718649

Country of ref document: EP

Publication	Publication Date	Title
CY1109274T1 (el)	2014-07-02	Παραγωγα ιμιδαζο[1,2-c] πυριμιδινυλοξικου οξεος
TW200505873A (en)	2005-02-16	Pyrimidine derivatives
EP2380891B1 (de)	2013-12-11	Substituierte Piperidino-Dihydrothienopyrimidine
MXPA05010055A (es)	2005-11-23	Derivados de 2-fenoxi- y 2-fenil-sulfomamida con actividad antagonista del ccr3, para el tratamiento del asma y otros desordenes inflamatorios o inmunologicos.
JO3041B1 (ar)	2016-09-05	مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
BR0314830A (pt)	2005-08-16	Derivados de azol-pirimidina fundida
NO996490L (no)	1999-12-27	Substituerte benzanilider som CCR5-reseptorligander, anti- inflammatoriske midler og antivirale midler
WO2004011427A3 (en)	2005-02-03	Substituted benzanilides as modulators of the ccr5 receptor
EA201100079A1 (ru)	2011-08-30	Производные триазоло[4,5-d]пирамидина и их применение в качестве антагонистов пуринового рецептора
CY1117974T1 (el)	2017-05-17	ΥΠΟΚΑΤΕΣΤΗΜΕΝΑ ΠΑΡΑΓΩΓΑ 1,2,3,4-ΤΕΤΡΑΫΔΡΟΚΥΚΛΟΠΕΝΤΑ[b]ΙΝΔΟΛ-3-ΥΛ-ΟΞΙΚΟΥ ΟΞΕΟΣ ΧΡΗΣΙΜΑ ΣΤΗΝ ΑΓΩΓΗ ΑΥΤΟΑΝΟΣΩΝ ΚΑΙ ΦΛΕΓΜΟΝΩΔΩΝ ΔΙΑΤΑΡΑΧΩΝ
MY157036A (en)	2016-04-15	2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists
WO2004010943A3 (en)	2004-09-16	Substituted benzanilides as modulators of the ccr5 receptor
ATE424402T1 (de)	2009-03-15	Imidazopyridinverbindungen
EA200802417A1 (ru)	2009-06-30	Замещенные фенилуксусные кислоты как dp-2-антагонисты
HRP20110414T1 (hr)	2011-08-31	Indoli i njihova uporaba u liječenju
NO20091489L (no)	2009-04-16	Tiazolpyrazolopyridiner som CRF1 reseptorantagonister
BRPI0409393A8 (pt)	2018-05-08	composto, composição farmacêutica, e, métodos para modulação de atividade de receptor de quimiocina em um mamífero, para tratamento, melhora, controle ou redução do risco de um distúrbio ou doença inflamatório e imunorregulatório, e de artrite reumatóide
JP2015517587A5 (de)	2017-08-31
WO2004010942A3 (en)	2004-07-08	Substituted heterocyclic compounds as modulators of the ccr5 receptor
NO20082297L (no)	2008-07-21	Piperazinderivater som er anvendelige som CCR5-antagonister
ATE270547T1 (de)	2004-07-15	Substituierte benzo(1,2-b:5,4-b')dipyran-4-amine als ccr5 modulatoren
TW200631954A (en)	2006-09-16	New pyridothienopyrimidine derivatives
Xia et al.	2008	Substituted dipiperidine alcohols as potent CCR2 antagonists
WO2005058898A3 (en)	2005-08-11	Purine compounds which can be used as phosphodiesterase (pde) type iv inhibitors
DE602006016244D1 (de)	2010-09-30	Diazaspiro-ä4,4ü-nonanderivate als neurokinin-(nk1)-antagonisten